For the quarter ending 2026-02-27, AEHR had $6,076K increase in cash & cash equivalents over the period. -$3,763K in free cash flow.
| Cash Flow | 2026-02-27 | 2025-11-28 | 2025-08-29 |
|---|---|---|---|
| Net income (loss) | - | -3,230 | -2,084 |
| Net loss | -8,517 | - | - |
| Stock-based compensation expense | 1,384 | 1,841 | 1,671 |
| Depreciation and amortization | 677 | 690 | 743 |
| Deferred income taxes | -807 | -1,201 | -761 |
| Amortization of operating lease right-of-use assets | 183 | 181 | 179 |
| Accounts receivable | 1,504 | -2,751 | -1,140 |
| Inventories | -857 | 872 | -218 |
| Prepaid expenses and other assets | 1,651 | -532 | -1,576 |
| Accounts payable | -1,362 | 287 | -2,401 |
| Accrued expenses | 445 | -988 | 505 |
| Deferred revenue | 1,431 | -676 | -863 |
| Operating lease liabilities | -139 | -482 | -215 |
| Income taxes payable | 0 | -4 | 10 |
| Net cash used in operating activities | -3,689 | -1,171 | -282 |
| Purchases of property and equipment | 74 | 467 | 1,391 |
| Payments for business acquisition, net of cash and cash equivalents acquired | 0 | 1,801 | 0 |
| Net cash used in investing activities | -74 | -2,268 | -1,391 |
| Proceeds from issuance of common stock from public offering, net of issuance costs | 10,224 | 9,371 | - |
| Proceeds from issuance of common stock under employee plans | 58 | 897 | 170 |
| Shares repurchased for tax withholdings on vesting of restricted stock units, amount | 454 | 491 | 328 |
| Net cash provided by financing activities | 9,828 | 9,777 | -158 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 11 | -11 | 9 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 6,076 | 6,327 | -1,822 |
| Cash, cash equivalents and restricted cash, beginning of period | 30,985 | 24,658 | 26,480 |
| Cash, cash equivalents and restricted cash, end of period | 37,061 | 30,985 | 24,658 |
AEHR TEST SYSTEMS (AEHR)
AEHR TEST SYSTEMS (AEHR)